Leave a legacy
in human and animal health
RLS Therapeutics is creating novel small molecule therapeutics from a proprietary class of compounds to treat a wide range of disease indications.
Join forward-thinking investors and partners in creating profoundly positive impacts in the treatment of diseases.
The Current Approach to Developing Treatments
We’ve seen it before. Current treatments . . .
Focus on symptom management
Miss the core mechanism of action in disease pathology
And therefore lack broad enough efficacy
How we’re different:
Better Odds.
Our goal is simple. We strive to decrease risk in drug development while pursuing drug candidates that profoundly affect human health. The RLS Therapeutics team and advisory board have the experience required to efficiently and effectively accelerate product development.
